Litcius/Paper detail

Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study

Danny Rischin, Madeleine King, Liz Kenny, Sandro Porceddu, Christopher Wratten, Andrew Macann, James E. Jackson, Mathias Bressel, Alan Herschtal, Richard Fisher, Tsien Fua, Charles Lin, Chen Liu, Brett Hughes, Margaret McGrath, Lachlan McDowell, June Corry

2021International Journal of Radiation Oncology*Biology*Physics152 citationsDOI

Topics & Concepts

CetuximabMedicineOncologyInternal medicineRadiation therapyCisplatinRandomized controlled trialRadiation oncologyCancerChemotherapyColorectal cancerHead and Neck Cancer StudiesEsophageal Cancer Research and TreatmentColorectal and Anal Carcinomas
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study | Litcius